AngioDynamics, Inc. (NASDAQ:ANGO) Stake Decreased by American International Group Inc.

American International Group Inc. cut its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 2.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 27,613 shares of the medical instruments supplier’s stock after selling 748 shares during the quarter. American International Group Inc.’s holdings in AngioDynamics were worth $631,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of ANGO. Arizona State Retirement System grew its stake in shares of AngioDynamics by 6.3% during the 4th quarter. Arizona State Retirement System now owns 57,167 shares of the medical instruments supplier’s stock worth $1,151,000 after purchasing an additional 3,385 shares during the period. Crossmark Global Holdings Inc. grew its stake in AngioDynamics by 43.5% in the 4th quarter. Crossmark Global Holdings Inc. now owns 14,876 shares of the medical instruments supplier’s stock valued at $299,000 after acquiring an additional 4,510 shares during the last quarter. Rhumbline Advisers grew its stake in AngioDynamics by 24.0% in the 4th quarter. Rhumbline Advisers now owns 108,257 shares of the medical instruments supplier’s stock valued at $2,179,000 after acquiring an additional 20,978 shares during the last quarter. State Board of Administration of Florida Retirement System grew its stake in AngioDynamics by 8.0% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 38,656 shares of the medical instruments supplier’s stock valued at $778,000 after acquiring an additional 2,858 shares during the last quarter. Finally, LS Investment Advisors LLC grew its stake in AngioDynamics by 419.1% in the 4th quarter. LS Investment Advisors LLC now owns 6,909 shares of the medical instruments supplier’s stock valued at $139,000 after acquiring an additional 5,578 shares during the last quarter. 98.46% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts recently commented on ANGO shares. BidaskClub cut shares of AngioDynamics from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 6th. Zacks Investment Research cut shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. ValuEngine cut shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Friday, April 19th. Finally, TheStreet cut shares of AngioDynamics from a “b” rating to a “c+” rating in a research note on Thursday, April 18th. Five investment analysts have rated the stock with a hold rating, AngioDynamics has a consensus rating of “Hold” and an average price target of $21.50.

Shares of NASDAQ ANGO opened at $19.46 on Wednesday. The stock has a market capitalization of $724.30 million, a P/E ratio of 26.30 and a beta of 0.71. AngioDynamics, Inc. has a 52 week low of $18.11 and a 52 week high of $25.48. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.70 and a current ratio of 2.68.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Tuesday, April 2nd. The medical instruments supplier reported $0.19 EPS for the quarter, missing the Zacks’ consensus estimate of $0.22 by ($0.03). The business had revenue of $86.34 million during the quarter, compared to analyst estimates of $88.30 million. AngioDynamics had a net margin of 1.30% and a return on equity of 5.41%. AngioDynamics’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.23 earnings per share. As a group, equities research analysts expect that AngioDynamics, Inc. will post 0.83 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “AngioDynamics, Inc. (NASDAQ:ANGO) Stake Decreased by American International Group Inc.” was posted by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.wkrb13.com/2019/06/12/angiodynamics-inc-nasdaqango-stake-decreased-by-american-international-group-inc.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

Read More: How to start trading in the forex market?

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.